LIFEVANTAGE CORP Derivative Liability, Current
LIFEVANTAGE CORP (LFVN) had Derivative Liability, Current of $0 as of 2012-03-31, per its 10-Q filed 2012-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2012-09-10
- 2012-03-31: Derivative Liability, Current $0.00.
- 2011-12-31: Derivative Liability, Current $6.06M.
- 2011-09-30: Derivative Liability, Current $6.85M.
- 2011-06-30: Derivative Liability, Current $7.44M.
| Period end | Derivative Liability, Current |
|---|---|
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 |
| 2011-12-31 | $6.06M 10-Q · filed 2012-02-14 |
| 2011-09-30 | $6.85M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $7.44M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |